Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine composition for treating postoperative complications of phacoemulsification

A phacoemulsification and cataract technology, which is applied in the field of medicine, can solve the problems of affecting the absorption of corneal inflammation, damaging the corneal epithelium, and ocular surface toxicity, and achieves the effects of no toxic side effects, rigorous prescription, and convenient preparation

Inactive Publication Date: 2015-07-15
QINGDAO CHENDA BIOLOGICAL SCI & TECH
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, long-term use of glucocorticoid eye drops may increase intraocular pressure and delay wound healing. Frequent use of various eye drops may cause ocular surface toxicity, damage the corneal epithelium, and affect the absorption of corneal inflammation.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine composition for treating postoperative complications of phacoemulsification
  • Medicine composition for treating postoperative complications of phacoemulsification
  • Medicine composition for treating postoperative complications of phacoemulsification

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] Example 1 tablet

[0030] Each raw material of the present invention is weighed according to the following weight proportions: Semen Cassiae 4g, Flos Lonicerae 2g, Peucedanum 2g, Fangfeng 4g, Tribulus terrestris 4g, Gentiana 6g, Cicada slough 5g, Ligusticum 2g, Citrus aurantium 6g, Campanulaceae 5g.

[0031] The preparation process is as follows:

[0032] Take the above Chinese medicine components according to the aforementioned weight and pulverize them into coarse powder respectively, decoct 3 times, add water 8 times the total weight of the medicine each time, decoct for 3 hours, merge the decoction liquid, filter; the filtrate is concentrated under reduced pressure into Extraction, add ethanol to make the alcohol content 75% v / v, let it stand for 48 hours, take the supernatant, recycle the ethanol to concentrate, dry at low temperature, pulverize the traditional Chinese medicine fine powder, and set aside.

[0033] Take 120g of traditional Chinese medicine fine pow...

Embodiment 2

[0035] Example 2 tablet

[0036] Each raw material of the present invention is weighed according to the following weight proportions: Semen Cassiae 4g, Flos Lonicerae 2g, Peucedanum 2g, Fangfeng 4g, Tribulus terrestris 4g, Gentiana 6g, Cicada slough 5g, Ligusticum 2g, Citrus aurantium 6g, Campanulaceae 5g.

[0037] The preparation process is as follows:

[0038] Take the above Chinese medicine components according to the aforementioned weight and pulverize them into coarse powder respectively, decoct 3 times, add water 8 times the total weight of the medicine each time, decoct for 3 hours, merge the decoction liquid, filter; the filtrate is concentrated under reduced pressure into Extraction, add ethanol to make the alcohol content 75% v / v, let it stand for 48 hours, take the supernatant, recycle the ethanol to concentrate, dry at low temperature, pulverize the traditional Chinese medicine fine powder, and set aside.

[0039] Take 120g of traditional Chinese medicine fine pow...

Embodiment 3

[0040] Example 3 tablet

[0041] Each raw material of the present invention is weighed according to the following weight proportions: Semen Cassiae 3g, Flos Lonicerae 3g, Peucedanum 1g, Fangfeng 5g, Tribulus terrestris 3g, Gentiana 7g, Cicada slough 4g, Ligusticum 3g, Citrus aurantium 5g, Campanulaceae 6g.

[0042] The preparation process is as follows:

[0043] Take the above Chinese medicine components according to the aforementioned weight and pulverize them into coarse powder respectively, decoct 3 times, add water 8 times the total weight of the medicine each time, decoct for 3 hours, merge the decoction liquid, filter; the filtrate is concentrated under reduced pressure into Extraction, add ethanol to make the alcohol content 75% v / v, let it stand for 48 hours, take the supernatant, recycle the ethanol to concentrate, dry at low temperature, pulverize the traditional Chinese medicine fine powder, and set aside.

[0044]Take 120g of traditional Chinese medicine fine powd...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of medical technologies, and particularly relates to a medicine composition for treating postoperative complications of phacoemulsification. The medicine composition is composed of semen cassia, honeysuckles, radix peucedani, saposhnicovia divaricata, white tribulus terrestris, gentians, periostracum cicadas, Ligusticum sinense Oliv, fructus aurantii immaturus, platycodon grandiflorum and the like. According to the medicine composition for treating the postoperative complications of the phacoemulsification, the treatative effect is obvious, the safety is high, the recurrence rate is low, and the medicine composition can be popularized and applied serving as an effective medicine for treating the postoperative complications of the phacoemulsification.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a pharmaceutical composition for treating complications after phacoemulsification cataract aspiration. Background technique [0002] After phacoemulsification was applied clinically in 1969, it was gradually abandoned in the late 1970s due to severe corneal complications. However, with the improvement of surgical equipment and methods and the reduction of complications, it can return to clinical practice and become the main way of treating cataract at present. However, corneal edema is one of the main complications after phacoemulsification cataract, and it is also one of the main reasons for affecting the vision recovery of patients. [0003] At present, western medicine routinely uses tobramycin and dexamethasone eye drops for anti-inflammation, prevention of infection, inhibition and reduction of inflammatory edema; compound tropicamide eye drops for moving pupil...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/752A61P27/12A61K35/64
Inventor 不公告发明人
Owner QINGDAO CHENDA BIOLOGICAL SCI & TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products